معرفی
Boris Juelg serves as Assistant Professor of Medicine at Harvard Medical School and Physician in the Division of Infectious Diseases at Massachusetts General Hospital (MGH). He holds dual roles as Principal Investigator and CTU Principal Investigator at the Center for Virology and Vaccine Research (CVVR), while also maintaining an Associate Membership at the Ragon Institute of MGH, MIT and Harvard.
His academic and clinical training includes:
- MD and PhD from Christian Albrecht University in Kiel, Germany
- Postdoctoral research fellowship with Dr. Bruce Walker
- Internal medicine residency at MGH
- Infectious diseases fellowship through MGH and Brigham and Women’s Hospital
Dr. Juelg operates at the critical intersection of clinical practice and laboratory science, specializing in translational HIV research. His work systematically bridges preclinical immunology with human clinical applications, focusing on passive immunization strategies using broadly neutralizing antibodies and active vaccine development. Through phase I/II clinical trials conducted in collaboration with the Ragon Institute, he pioneers the translation of laboratory discoveries into tangible prevention and treatment protocols for HIV infection, with particular emphasis on cure-oriented approaches.
He contributes to national research infrastructure as a member of the AIDS Clinical Trials Group (ACTG) Cure Transformative Science Group and serves on the MGH Committee for Clinical Research. His principal investigator role encompasses leadership of multi-institutional clinical trials funded through federal and foundation grants.
Dr. Juelg operates within the Center for Virology and Vaccine Research (CVVR) ecosystem at Harvard Medical School, collaborating with a cohort of principal investigators including Dan H. Barouch and Ai-ris Yonekura Collier. His work is embedded within the Ragon Institute's collaborative framework that unites Harvard, MIT, and MGH resources for immunological breakthroughs.
